Skip to main content

TWO SIGMA INVESTMENTS, LP

Position in TXG — 10x Genomics, Inc.

CIK 1179392 NEW YORK, NY

Position in TXG

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$8,543,525
-$10,305,795 QoQ
Shares Held
402,427
-65.2% QoQ
Ownership
0.317%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
20 quarters on record
Voting authority Sole 96.44656049420142.ToString("F0")% Shared 0.ToString("F0")% None 3.5534395057985675.ToString("F0")%

Common Shares in TXG Over Time

Shares Held

Position Value (USD)

Derivatives in TXG

reported options exposure · as of Dec 31, 2021
CallValue
$670,320
CallShares
4,500
PutValue
$1,042,720
PutShares
7,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Health Information Services

Healthcare · as of Mar 31, 2026

TWO SIGMA INVESTMENTS, LP holds $489,155,632 across 27 Health Information Services names. TXG ranks #7 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 TXG
10x Genomics, Inc.
This page
402,427 $8,543,525

All Filings in TXG

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,543,525 402,427
2025-12-31 $18,849,320 1,155,691
2025-09-30 $6,913,395 591,394
2025-06-30 $11,878,312 1,025,761
2025-03-31 $12,442,039 1,425,205
2024-12-31 $18,947,833 1,319,487
2024-09-30 $7,615,872 337,284
2024-06-30 $2,660,312 136,777
2024-03-31 $1,627,000 43,352
2023-12-31 $2,333,532 41,700
2023-09-30 $1,245,750 30,200
2023-06-30 $8,369,690 149,887
2023-03-31 $1,400,329 25,100
2022-12-31 $8,586,830 235,643
2022-09-30 $10,115,184 355,168
2022-06-30 $6,896,371 152,406
2022-03-31 $4,871,370 64,038
2021-12-31 $670,320 4,500
2021-12-31 $1,042,720 7,000
2021-03-31 $15,551,701 85,921
2020-12-31 $9,954,480 70,300